In this issue, Yamashita et al.1 present the experience of the University of Tokyo with portal vein embolization (PVE) in 338 patients from 1995 to 2013. The authors should be congratulated for presenting an extensive review of their indication, technique, and outcome of PVE. Over the past two decades, PVE has become an invaluable procedure in hepatic surgery. This editorial is an opportunity to revisit the indications for the procedure, the techniques to optimize the hypertrophy, and the methods to quantify its effects on regeneration.In the study, Yamashita et al. used as indication for PVE a cut-off future liver remnant (FLR) volume of \40% in patients with normal liver function based on an indocyanine green retention rate at 15 min (ICGR15) of \10%. This cautious approach was associated with an excellent outcome following resection, with an hepatic insufficiency rate of 2% and 90-day mortality of 0.8%. Anatomically, the left liver, on average, accounts for 33% of the total liver volume (TLV), and a 40% cut-off implies that the majority of patients undergoing right hepatectomy should receive PVE, which seems unnecessary.2 As such, the 40% cut-off value for PVE is higher than the 20-30% used in the West, and the study may include more PVEs than clinically indicated. In our own experience with 301 extended right hepatectomies in patients with normal liver function, we demonstrated that patients with 20-30% FLR had similar postoperative outcomes compared with patients with 30-40% FLR, and only the subset of patients with B20% FLR had increased hepatic insufficiency and perioperative mortality. At MD Anderson Cancer Center, we recommend PVE for FLR of B20% in normal liver, B30% in injured liver, and B40% in fibrosis/cirrhosis. 4,5 Using appropriate indications for PVE, tailoring the procedure based on accurate volumetry and avoiding overutilization are important because PVE remains a procedure with a 7.8% risk of associated complications, as reported in the series of the University of Tokyo.Yamashita et al. report an excellent degree of hypertrophy (median 10%) and kinetic growth rate (3.9-4.5% per week). In contrast, they report a median regeneration rate of 25% following PVE, which was lower than the regeneration rate of 62% following PVE in a recent series of 103 patients undergoing resection of colorectal liver metastases with small liver remnants. 6 The lower regeneration rate in the series from the University of Tokyo may be attributed to generous indications for PVE and the performance of PVE in patients with an already large FLR unlikely to undergo significant regeneration. The technique recently used at the University of Tokyo is alcohol injection, which has led to less recanalization of the portal vein. It would have been interesting for the authors to compare the hypertrophy rates between alcohol injection and Gelfoam plus coil particle previously used by the authors. An important aspect of the technique at the University of Tokyo is the minimal use of segment 4 embolization (6/ 319, 1.9%) in spite of ...